Skip to search formSkip to main contentSkip to account menu

tigemonam

Known as: Acetic acid, (((1-(2-amino-4-thiazolyl)-2-((2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl)amino)-2-oxoethylidene)amino)oxy)-, (S-(Z))- 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Monobactams

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Comparative antimicrobial activity of ceftibuten against multiply-resistant microorganisms from Belgium.
1989
1989
The In Vitro Activity of Tigemonam: a Comparison with Other Antimicrobial Agents.
The activity of tigemonam was compared with that of aztreonam, cefuroxime, cephalexin, amoxicillin/clavulanate potassium… 
1989
1989
Tigemonam activity against clinical isolates of Enterobacteriaceae and Enterobacteriaceae with known mechanisms of resistance to beta-lactam antibiotics.
Tigemonam, a new oral monobactam, was at least as active as aztreonam or carumonam against clinical isolates of… 
1989
1989
Growth Curve Patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris Submitted to Different Tigemonam Concentrations.
Five strains of Escherichia coli, Serratia marcescens, and Proteus vulgaris were exposed to a new monobactam, tigemonam, in… 
1988
1988
Tigemonam, an oral monobactam
Tigemonam is an orally administered monobactam. At less than or equal to 1 microgram/ml it inhibited the majority of strains of… 
1988
1988
The New Monobactams: Chemistry and Biology
The discovery of the monobactams led to the successful development of aztreonam as the first of this novel class of beta‐lactam… 
1988
1988
In vitro antimicrobial activity of tigemonam, a new orally administered monobactam
At five geographically separate medical centers, over 6,000 clinical bacterial isolates were tested for their susceptibility to… 
1988
1988
Comparative in-vitro activity of tigemonam, a new monobactam.
The in-vitro activity against Gram-negative aerobic bacterial pathogens of a new oral monobactam, tigemonam, was compared with… 
1987
1987
In vitro evaluation of tigemonam, a novel oral monobactam
Tigemonam, a novel, orally administered monobactam, exhibited potent and specific activity in vitro against members of the family… 
1987
1987
In vivo evaluation of tigemonam, a novel oral monobactam
Tigemonam, a new monobactam with excellent activity against gram-negative bacteria, was evaluated for in vivo efficacy and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)